Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Allakos Inc (ALLK) Insider Trading Activity
Healthcare • Biotechnology • 131 employees
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Total Value
-$159,663.70
Total Shares
-195,611
Average Trade Value
-$19,957.96
Most Active Insider
Alexander Robert
Total Activity: $57,353
Largest Single Transaction
$35,713
by Alexander Robert on Dec 5, 2024
30-Day Activity
4 Transactions
Volume: 77,354 shares
Value: $85,408
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
President
|
Dec 6, 2024 | 21,116 | $23,228 | 532,647 (-4.0%) | Payment of Exercise Price | |
|
Chief Financial Officer
|
Dec 6, 2024 | 13,138 | $14,452 | 177,587 (-7.4%) | Payment of Exercise Price | |
|
Chief Executive Officer
|
Dec 5, 2024 | 32,466 | $35,713 | 769,474 (-4.2%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Dec 4, 2024 | 10,634 | $12,016 | 275,046 (-3.9%) | Payment of Exercise Price | |
|
Chief Executive Officer
|
Sep 11, 2024 | 37,311 | $21,640 | 801,940 (-4.7%) | Payment of Exercise Price | |
|
Chief Medical Officer
|
Sep 9, 2024 | 45,320 | $29,458 | 285,680 (-15.9%) | Payment of Exercise Price | |
|
President
|
Sep 6, 2024 | 21,961 | $14,275 | 553,763 (-4.0%) | Payment of Exercise Price | |
|
Chief Financial Officer
|
Sep 6, 2024 | 13,665 | $8,882 | 190,725 (-7.2%) | Payment of Exercise Price |